Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
FDA published its determination that LUPRON DEPOT, an injectable vial containing 3.75 milligrams of the drug, was not withdrawn from sale for reasons of safety or effectiveness.
United StatesFood, Drugs, Healthcare, Life Sciences
In the October 8, 2014,Federal Register, FDA published its
determination that LUPRON DEPOT (leuprolide acetate for depot
suspension), an injectable vial containing 3.75 milligrams of the
drug, was not withdrawn from sale for reasons of safety or
effectiveness.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.